This report assembles a global sector overview, including details on financings, partnerships and other deals, clinical trial information, major clinical data events, and ARM’s current legislative and regulatory priorities.
Regenerative Medicine Companies
Worldwide, Including Gene and
Cell Therapies, and Tissue Engineering
Therapeutic Developers
Increase from Q1 2017
Increase from Q1 2017
Increase from Q1 2017
Increase from Q1 2017
959
Clinical trials underway
worldwide by the end of Q1 2018
320
549
90
